ArticleFrontiers in neurology
Clinical differences between elderly and non-elderly chronic subdural hematoma patients.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Chronic subdural hematoma (CSDH) is a common disease in elderly population, which can also be seen in young and middle-aged individuals. In order to understand the clinical features of this disease deeply, we conducted this retrospective study to clarify the clinical differences between elderly and non-elderly CSDH patients. Methods: According to the inclusion and exclusion criteria, 268 elderly CSDH patients and 87 non-elderly CSDH patients were recruited from January 2015 to December 2024 in our cohort. The collected data and compared parameters including baseline clinical features and radiological outcomes of hematoma within 24 h of hospital admission, as well as the treatment method and clinical outcome of elderly and non-elderly CSDH patients. Results: Compared to non-elderly CSDH patients, female was more frequent, the traumatic events were less common, and the history of taking anticoagulants and antiplatelet drugs were more common in elderly CSDH patients (all Conclusion: Elderly CSDH patients were less likely to have the traumatic events and more likely to have the history of taking anticoagulants/antiplatelet drugs, who were also owing the higher rate of using atorvastatin and hematoma recurrence, compared to non-elderly CSDH patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.